Drug Type Small molecule drug |
Synonyms iloma, 이로마정 |
Target |
Action antagonists, inhibitors |
Mechanism FXR antagonists(Bile acid receptor FXR antagonists), Proton pump inhibitors |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
License Organization- |
Drug Highest PhaseApproved |
First Approval Date South Korea (21 Apr 2025), |
Regulation- |
Molecular FormulaC24H40O4 |
InChIKeyRUDATBOHQWOJDD-UZVSRGJWSA-N |
CAS Registry128-13-2 |
Indication | Country/Location | Organization | Date |
---|---|---|---|
Abdomen distended | South Korea | 21 Apr 2025 | |
Anorexia | South Korea | 21 Apr 2025 | |
Constipation | South Korea | 21 Apr 2025 | |
Hemorrhoids | South Korea | 21 Apr 2025 |